Main Topic Area
All Topic Areas
1 - 10 of 960 more >>
Articles
1 - 5 of 13 more >>
- Oral Contraceptives and Cancer Risk
Key Points There is evidence of an increased risk of breast cancer for women under age 35 who are recent users of OCs (see section on Breast Cancer). Studies have consistently shown that using OCs reduces the risk of ovarian cancer (see section on Ovarian and Endometrial Cancers). There is evidence that long-term use of OCs may increase the risk of cancer of the cervix (see section on Cancer of the Cervix). There is some evidence that OCs may increase the risk of certain cancerous liver tumors...
- Lip and Oral Cavity Cancer Treatment
Treatment depends on where the cancer is in the lip or mouth. Treatment depends on where the cancer is in the lip or mouth. In addition to the treatments listed below, a patient will probably have radiation therapy to the neck with or without surgery to remove lymph nodes in the neck (lymph node dissection). Treatment depends on the type of treatment the patient had before. If radiation therapy was given, the patient may have surgery when the cancer comes back. If surgery was used, the patient...
National Cancer Institute
- Oral Complications of Chemotherapy and Radiation
This patient summary on oral complications of cancer and cancer therapy is adapted from the summary written for health professionals by cancer experts. This and other accurate, credible information about cancer treatment, screening, prevention, supportive care, and ongoing clinical trials is available from the National Cancer Institute. Oral complications are common in cancer patients, especially those with head and neck cancer. This summary describes oral complications caused by chemotherapy...
National Cancer Institute
- Oral Insulin Does Not Prevent Type 1 Diabetes
Insulin taken orally does not delay or prevent type 1 diabetes in people at moderate risk (25 to 50 percent likelihood) of developing type 1 diabetes in 5 years, researchers reported today at the annual meeting of the American Diabetes Association. The finding emerged from the second trial conducted as part of the Diabetes Prevention Trial-Type 1 (DPT-1), which ended last month. The other DPT-1 trial, completed two years ago, found that low-dose insulin injections failed to prevent or delay...
National Institutes of Health
- Interstitial Cystitis Study Finds Limited Benefit in Two Oral Drugs
An 18-month pilot study of two commonly available treatments has shown no significant benefit in patients with interstitial cystitis (IC). The results are reported in the September issue of the Journal of Urology. The first in a series of treatment studies planned by the IC Clinical Trials Group tested the effectiveness of pentosan polysulfate sodium (Elmiron®) and hydroxyzine hydrochloride (Atarax®) in 121 patients with IC. Most volunteers reported experiencing moderate pain, discomfort, and...
National Institutes of Health
Organizations
1 - 5 of 7 more >>
- Oral Cancer Foundation -
- American Association of Oral and Maxillofacial Surgeons -
- National Oral Health Information Clearinghouse -
- Support for People with Oral and Head and Neck Cancer, Inc. - http://www.spohnc.org/
- Division of Oral Health, NCCDPHP, CDC, OPHS, HHS - http://www.cdc.gov/nccdphp/oh/index.htm
News
1 - 5 of 738 more >>
- Ranbaxy Gains FDA Approval To Market Amoxicillin And Clavulanate Potassium For Oral Suspension USP
MedicalNewsToday - Thu, 01 Feb 2007 08:00 EST
- Wyeth And Progenics To Begin Clinical Testing Of A New Formulation Of Oral Methylnaltrexone Based On Phase 2 Findings
MedicalNewsToday - Wed, 07 Mar 2007 08:00 EST
- King's College London Launches The First Global Initiative To Improve Child Oral Health
MedicalNewsToday - Mon, 05 Mar 2007 08:00 EST
- Expert Medical And Dental Panel Affirm Link Between Oral Health And Overall Well-Being
MedicalNewsToday - Thu, 01 Mar 2007 08:00 EST
- Initiation Of Phase III Program Using Emisphere's Eligen(R) Technology For Oral Salmon Calcitonin
MedicalNewsToday - Wed, 28 Feb 2007 08:00 EST
Clinical Trials
1 - 5 of 1086 more >>
- Oral acyclovir for neonatal HSV disease of the skin,eyes and mouth
ClinicalTrials.gov Identifier: NCT00031447 - Active, not recruiting
Herpes Simplex
- Assessment of oral acyclovir in neonates with HSV involving the CNS
ClinicalTrials.gov Identifier: NCT00031460 - Active, not recruiting
Herpes Simplex
- Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients with Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00071201 - Active, not recruiting
Chronic Hepatitis B
- A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children
ClinicalTrials.gov Identifier: NCT00297206 - Active, not recruiting
Herpes Simplex
- An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00442208 - Active, not recruiting
Healthy

Not Signed In -

